123 related articles for article (PubMed ID: 10826314)
1. Biological basis of radiation sensitivity. Part 1: Factors governing radiation tolerance.
Rosen EM; Fan S; Goldberg ID; Rockwell S
Oncology (Williston Park); 2000 Apr; 14(4):543-50. PubMed ID: 10826314
[TBL] [Abstract][Full Text] [Related]
2. The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation.
Rosen EM; Fan S; Rockwell S; Goldberg ID
Cancer Invest; 1999; 17(1):56-72. PubMed ID: 10999050
[TBL] [Abstract][Full Text] [Related]
3. Biological basis of radiation sensitivity. Part 2: Cellular and molecular determinants of radiosensitivity.
Rosen EM; Fan S; Goldberg ID; Rockwell S
Oncology (Williston Park); 2000 May; 14(5):741-57; discussion 757-8, 761-6. PubMed ID: 10853463
[TBL] [Abstract][Full Text] [Related]
4. [Normal tissue tolerance to external beam radiation therapy: bone marrow].
Drouet F; Lagrange JL
Cancer Radiother; 2010 Jul; 14(4-5):392-404. PubMed ID: 20598617
[TBL] [Abstract][Full Text] [Related]
5. The role of amifostine as a radioprotector.
Wasserman TH; Brizel DM
Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
[TBL] [Abstract][Full Text] [Related]
6. [Interactive determination of the parameters of mathematical models for planning radiotherapy of malignant tumors. I. Mathematical models for calculating dose tolerance, adequate doses and the likelihood of development of radiation complications in normal organs and tissues].
Klepper LIa
Med Tekh; 2000; (4):37-41. PubMed ID: 10984881
[TBL] [Abstract][Full Text] [Related]
7. Relevance and irrelevance of DNA damage response to radiotherapy.
Connell PP; Kron SJ; Weichselbaum RR
DNA Repair (Amst); 2004; 3(8-9):1245-51. PubMed ID: 15279813
[TBL] [Abstract][Full Text] [Related]
8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
9. Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation.
Milas L; Fang FM; Mason KA; Valdecanas D; Hunter N; Koto M; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):568-72. PubMed ID: 17236972
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
Hall EJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
[TBL] [Abstract][Full Text] [Related]
11. [Perspectives in biological modulation of radiotherapy].
Deutsch E; Huguet F
Bull Cancer; 2005 Jan; 92(1):90-6. PubMed ID: 16123013
[TBL] [Abstract][Full Text] [Related]
12. Superfractionation: its rationale and anticipated benefits.
Douglas BG
Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1143-53. PubMed ID: 7118617
[TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of individual radiosensitivity.
Benotmane MA
J Biol Regul Homeost Agents; 2004; 18(3-4):357-62. PubMed ID: 15786705
[TBL] [Abstract][Full Text] [Related]
14. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
15. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
Lee TK; Stupans I
J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
[TBL] [Abstract][Full Text] [Related]
16. Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources.
Vikram B; Coleman CN; Deye JA
Oncology (Williston Park); 2009 Mar; 23(3):279-83. PubMed ID: 19418829
[TBL] [Abstract][Full Text] [Related]
17. [Individual response to ionising radiation: What predictive assay(s) to choose?].
Granzotto A; Joubert A; Viau M; Devic C; Maalouf M; Thomas C; Vogin G; Malek K; Colin C; Balosso J; Foray N
C R Biol; 2011 Feb; 334(2):140-57. PubMed ID: 21333944
[TBL] [Abstract][Full Text] [Related]
18. Cellular, molecular, and carcinogenic effects of radiation.
Little JB
Hematol Oncol Clin North Am; 1993 Apr; 7(2):337-52. PubMed ID: 8468269
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy tolerance limits. For one or for all?--Janeway Lecture.
Peters LJ
Cancer; 1996 Jun; 77(11):2379-85. PubMed ID: 8635110
[TBL] [Abstract][Full Text] [Related]
20. [Biomodulation and radiotherapy].
Bourhis J; Lartigau E
Cancer Radiother; 2000 Nov; 4 Suppl 1():128s-133s. PubMed ID: 11194950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
